US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
from NDTV News - India-news https://ift.tt/3bIUCMT
via
Welcome To Basil
0 Comments